FourThought Financial Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-529
| Closed | -$336K | – | 332 |
|
|
2025
Q1 | $336K | Sell |
529
-82
| -13% | -$52K | 0.04% | 229 |
|
|
2024
Q4 | $435K | Buy |
+611
| New | +$435K | 0.05% | 200 |
|
|
2024
Q2 | – | Sell |
-688
| Closed | -$662K | – | 296 |
|
|
2024
Q1 | $662K | Sell |
688
-18
| -3% | -$17.3K | 0.08% | 168 |
|
|
2023
Q4 | $620K | Sell |
706
-12
| -2% | -$10.5K | 0.08% | 171 |
|
|
2023
Q3 | $591K | Sell |
718
-13
| -2% | -$10.7K | 0.08% | 164 |
|
|
2023
Q2 | $525K | Sell |
731
-53
| -7% | -$38.1K | 0.07% | 185 |
|
|
2023
Q1 | $644K | Sell |
784
-12
| -2% | -$9.86K | 0.09% | 158 |
|
|
2022
Q4 | $574K | Buy |
+796
| New | +$574K | 0.08% | 174 |
|